From February 26, 2024 to March 26, 2024, the company has repurchased 210,800 shares, representing 6.33% for ¥189.93 million. With this, the company has completed the repurchase of 210,800 shares, representing 6.33% for ¥189.93 million under the buyback announced on February 26, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,076 JPY | -0.37% | -0.74% | +7.49% |
1st Jan change | Capi. | |
---|---|---|
+7.49% | 22.85M | |
-12.48% | 8.57B | |
+34.64% | 1.32B | |
+6.10% | 419M | |
+8.08% | 282M | |
+10.56% | 224M | |
-8.26% | 85.07M | |
+21.18% | 59.57M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.